tradingkey.logo

Concentra Group Holdings Parent Inc

CON
22.082USD
-0.098-0.44%
Trading geöffnet ETKurse um 15 Minuten verzögert
2.83BMarktkapitalisierung
14.84KGV TTM

Concentra Group Holdings Parent Inc

22.082
-0.098-0.44%

mehr Informationen über Concentra Group Holdings Parent Inc Unternehmen

Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. It delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care, to more than 50,000 patients each day, on average, from about 620 occupational health centers in 41 states and 160 onsite health clinics at employer worksites in 36 states. Its Occupational Health Centers segment encompasses the services it delivers at its occupational health center facilities across the United States. Its Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services. Its Other Businesses segment comprises several complementary services to its core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration.

Concentra Group Holdings Parent Inc Informationen

BörsenkürzelCON
Name des UnternehmensConcentra Group Holdings Parent Inc
IPO-datumJul 25, 2024
CEONewton (William Keith)
Anzahl der mitarbeiter8758
WertpapierartOrdinary Share
GeschäftsjahresendeJul 25
Addresse5080 Spectrum Drive
StadtADDISON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl75001
Telefon19723648000
Website
BörsenkürzelCON
IPO-datumJul 25, 2024
CEONewton (William Keith)

Führungskräfte von Concentra Group Holdings Parent Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Chairman of the Board
Chairman of the Board
8.17M
-79260.00%
Mr. William Keith Newton
Mr. William Keith Newton
Chief Executive Officer, Director
Chief Executive Officer, Director
393.75K
-89081.00%
Mr. Thomas Devasia
Mr. Thomas Devasia
Executive Vice President, Chief Marketing and Innovation Officer
Executive Vice President, Chief Marketing and Innovation Officer
114.10K
+54097.00%
Mr. Giovanni Gallara
Mr. Giovanni Gallara
Executive Vice President, Chief Clinical Services Officer
Executive Vice President, Chief Clinical Services Officer
113.44K
+53437.00%
Ms. Danielle Kendall
Ms. Danielle Kendall
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
76.06K
+36065.00%
Mr. Matthew T. Dicanio
Mr. Matthew T. Dicanio
President, Chief Financial Officer
President, Chief Financial Officer
--
--
Dr. John R. Anderson
Dr. John R. Anderson
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. John A. Delorimier
Mr. John A. Delorimier
Executive Vice President, Chief Digital and Data Officer
Executive Vice President, Chief Digital and Data Officer
--
--
Mr. Michael A. Kosuth
Mr. Michael A. Kosuth
Executive Vice President, Chief Operating Officer - East
Executive Vice President, Chief Operating Officer - East
--
--
Mr. Douglas R. Mcandrew
Mr. Douglas R. Mcandrew
Executive Vice President, Chief Operating Officer - West
Executive Vice President, Chief Operating Officer - West
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Chairman of the Board
Chairman of the Board
8.17M
-79260.00%
Mr. William Keith Newton
Mr. William Keith Newton
Chief Executive Officer, Director
Chief Executive Officer, Director
393.75K
-89081.00%
Mr. Thomas Devasia
Mr. Thomas Devasia
Executive Vice President, Chief Marketing and Innovation Officer
Executive Vice President, Chief Marketing and Innovation Officer
114.10K
+54097.00%
Mr. Giovanni Gallara
Mr. Giovanni Gallara
Executive Vice President, Chief Clinical Services Officer
Executive Vice President, Chief Clinical Services Officer
113.44K
+53437.00%
Ms. Danielle Kendall
Ms. Danielle Kendall
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
76.06K
+36065.00%
Mr. Matthew T. Dicanio
Mr. Matthew T. Dicanio
President, Chief Financial Officer
President, Chief Financial Officer
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Occupational health centers - Workers compensation
343.45M
59.96%
Occupational health centers - Employer services
173.23M
30.24%
Onsite clinics
34.90M
6.09%
Other
11.87M
2.07%
Occupational health centers - Consumer health
7.39M
1.29%
Other occupational health center revenue
1.95M
0.34%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Occupational health centers - Workers compensation
343.45M
59.96%
Occupational health centers - Employer services
173.23M
30.24%
Onsite clinics
34.90M
6.09%
Other
11.87M
2.07%
Occupational health centers - Consumer health
7.39M
1.29%
Other occupational health center revenue
1.95M
0.34%

Aktionärsstatistik

Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
T. Rowe Price Associates, Inc.
13.28%
BlackRock Institutional Trust Company, N.A.
12.38%
The Vanguard Group, Inc.
9.81%
Ortenzio (Robert A)
6.37%
T. Rowe Price Investment Management, Inc.
4.88%
Andere
53.28%
Aktionäre
Aktionäre
Anteil
T. Rowe Price Associates, Inc.
13.28%
BlackRock Institutional Trust Company, N.A.
12.38%
The Vanguard Group, Inc.
9.81%
Ortenzio (Robert A)
6.37%
T. Rowe Price Investment Management, Inc.
4.88%
Andere
53.28%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
59.39%
Investment Advisor/Hedge Fund
18.16%
Individual Investor
10.64%
Hedge Fund
6.49%
Research Firm
2.52%
Sovereign Wealth Fund
1.21%
Pension Fund
1.18%
Bank and Trust
0.72%
Insurance Company
0.03%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
468
115.54M
92.17%
+1.31K
2025Q3
468
115.54M
92.15%
+6.14M
2025Q2
437
109.05M
87.68%
-456.06K
2025Q1
406
109.58M
85.04%
+578.97K
2024Q4
355
109.93M
36.49%
+63.12M
2024Q3
113
28.34M
4.83%
+22.18M

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
T. Rowe Price Associates, Inc.
17.02M
13.28%
+3.26M
+23.67%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
15.86M
12.38%
+588.62K
+3.85%
Sep 30, 2025
The Vanguard Group, Inc.
13.18M
10.28%
+27.92K
+0.21%
Sep 30, 2025
Ortenzio (Robert A)
8.17M
6.37%
-79.26K
-0.96%
Nov 25, 2025
T. Rowe Price Investment Management, Inc.
6.26M
4.88%
-1.40M
-18.30%
Sep 30, 2025
State Street Investment Management (US)
4.42M
3.45%
+152.67K
+3.57%
Sep 30, 2025
Rocco A. Ortenzio UEO
3.30M
2.57%
-3.07M
-48.22%
Mar 03, 2025
Thrivent Asset Management, LLC
3.25M
2.53%
+945.30K
+41.09%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
3.10M
2.42%
-98.02K
-3.06%
Sep 30, 2025
JP Morgan Asset Management
3.10M
2.42%
+425.09K
+15.92%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Texas Capital Texas Small Cap Equity Index ETF
2.5%
State Street SPDR S&P Health Care Services ETF
1.88%
Invesco S&P SmallCap Health Care ETF
1.45%
Harbor Human Capital Factor US Small Cap ETF
0.8%
JPMorgan Active Small Cap Value ETF
0.79%
Texas Capital Texas Equity Index ETF
0.62%
Invesco S&P SmallCap Quality ETF
0.54%
JPMorgan Fundamental Data Science Small Core ETF
0.51%
T Rowe Price Small-Mid Cap ETF
0.45%
iShares U.S. Healthcare Providers ETF
0.37%
Mehr Anzeigen
Texas Capital Texas Small Cap Equity Index ETF
Anteil2.5%
State Street SPDR S&P Health Care Services ETF
Anteil1.88%
Invesco S&P SmallCap Health Care ETF
Anteil1.45%
Harbor Human Capital Factor US Small Cap ETF
Anteil0.8%
JPMorgan Active Small Cap Value ETF
Anteil0.79%
Texas Capital Texas Equity Index ETF
Anteil0.62%
Invesco S&P SmallCap Quality ETF
Anteil0.54%
JPMorgan Fundamental Data Science Small Core ETF
Anteil0.51%
T Rowe Price Small-Mid Cap ETF
Anteil0.45%
iShares U.S. Healthcare Providers ETF
Anteil0.37%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 7.96M USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 06, 2025
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Dec 09, 2025 going ex on Dec 02, 2025
Dec 02, 2025
Dec 09, 2025
Dec 02, 2025
Aug 07, 2025
CON.NB Final Cash Dividend of gross USD 0.0625 paid on Aug 28, 2025 going ex on Aug 21, 2025
Aug 21, 2025
Aug 28, 2025
Aug 21, 2025
May 07, 2025
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on May 29, 2025 going ex on May 20, 2025
May 20, 2025
May 29, 2025
May 20, 2025
Feb 28, 2025
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Apr 01, 2025 going ex on Mar 18, 2025
Mar 18, 2025
Apr 01, 2025
Mar 18, 2025
Oct 31, 2024
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Nov 22, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 22, 2024
Nov 13, 2024

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI